GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Price-to-Funds-From-Operations

Biosergen AB (OSTO:BIOSGN) Price-to-Funds-From-Operations : (As of May. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Biosergen AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.